Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | FAAH | O00519 | 4/20 | 0.59 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.56 |
| ▸ | CASP2 | P42575 | 1/20 | 0.55 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.54 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.54 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.54 |
| ▸ | PAM | P19021 | 2/20 | 0.51 |
| ▸ | NAAA | Q02083 | 1/20 | 0.51 |
| ▸ | CNR1 | P21554 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8921826 | 1.00 | DGKA (0.67) | DGKAL3MBTL1FAAHDNM1CASP2 | |
| SCHEMBL8920199 | 1.00 | DGKA (0.67) | DGKAL3MBTL1FAAHDNM1CASP2 | |
| SCHEMBL8922042 | 1.00 | DGKA (0.67) | DGKAL3MBTL1FAAHDNM1CASP2 | |
| SCHEMBL8921681 | 1.00 | DGKA (0.67) | DGKAL3MBTL1FAAHDNM1CASP2 | |
| SCHEMBL20856388 | 1.00 | DGKA (0.67) | DGKAL3MBTL1FAAHDNM1CASP2 | |
| SCHEMBL8920345 | 1.00 | DGKA (0.67) | DGKAL3MBTL1FAAHDNM1CASP2 | |
| SCHEMBL21302767 | 0.95 | DGKA (0.59) | DGKAL3MBTL1FAAHDNM1CASP2 | |
| SCHEMBL22269386 | 0.92 | EPHX2 (0.57) | DGKAL3MBTL1FAAHPAMCNR1 | |
| SCHEMBL9860855 | 0.91 | LPAR1 (0.67) | LPAR1LPAR2ENPP2CNR1 | |
| SCHEMBL9860844 | 0.91 | LPAR1 (0.67) | LPAR1LPAR2ENPP2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1639 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115155-A1 | STABLE FORMS OF CAPSAICIN PALMITATE FOR THE TREATMENT OF PAIN | CHORDA PHARMA INC (US) | 2026-04-30 | — | — | US | claimed |
| CN-119465669-A | Dyeing liquid for optical resin, dyed optical resin, and preparation method and application of dyed optical resin | 拓烯科技(衢州)有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119410187-A | Extinction liquid for lens barrel, extinction lens barrel, preparation method and application of extinction liquid | 拓烯科技(衢州)有限公司 | 2025-02-11 | — | — | CN | claimed |
| CN-119194880-A | Dyeing assistant composition for optical resin dyeing, dyeing method of optical resin and dyed optical resin | 拓烯科技(衢州)有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-118621601-A | Dyeing liquid for optical resin and preparation method and application thereof | 拓烯科技(衢州)有限公司 | 2024-09-10 | — | — | CN | claimed |
| US-12070516-B2 | Hair styling compositions | L'OREAL (FR) | 2024-08-27 | — | — | US | claimed |
| US-20240197597-A1 | HAIR STYLING COMPOSITIONS | L'OREAL (FR) | 2024-06-20 | — | — | US | claimed |
| US-20220370965-A1 | METHOD, SYSTEM, APPARATUS AND FORMULATIONS FOR PRODUCING OIL-BASED BLENDS AND MICROEMULSIONS AND NANOEMULSIONS | FERNANDES SERODIO JOAO CARLOS (GB) | 2022-11-24 | — | — | US | claimed |
| EP-4055127-A1 | METHOD, SYSTEM, APPARATUS AND FORMULATIONS FOR PRODUCING OIL-BASED BLENDS AND MICROEMULSIONS AND NANOEMULSIONS | Fernandes Serodio, Joao Carlos (GB) | 2022-09-14 | — | — | EP | claimed |
| CN-114796442-A | A composition containing plant extract for treating scar and its product | 上海资医堂生物科技有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-106764443-A | Thickener suitable for poly alpha-olefin oil product drag reducer | 刘政 | 2017-05-31 | — | — | CN | claimed |
| EP-2115089-B1 | USE OF HOLLOW BODIES FILLED WITH MELTABLE MATERIALS AS LATENT HEAT ACCUMULATORS | ALZCHEM AG (DE) | 2013-03-13 | — | — | EP | claimed |
| CN-102939149-A | Method for preparing non-ionic surfactant stable personal care dispersion | PROCTER & GAMBLE | 2013-02-20 | — | — | CN | claimed |
| US-5925604-A | SHAMPOO OR BEAUTY SOAPS THAT ADD LUSTER AND SHEEN FROM EMULSIFIERS AND SURFACTANTS | RHODIA INC. (US) | 1999-07-20 | — | — | US | claimed |
| EP-0862413-A1 | MILD COLD PEARLIZING CONCENTRATES | RHONE-POULENC INC. (US) | 1998-09-09 | — | — | EP | claimed |
| WO-1997013498-A1 | MILD COLD PEARLIZING CONCENTRATES | RHONE-POULENC INC. (US) | 1997-04-17 | — | — | WO | claimed |
| US-5602208-A | LUBRICANTS, MOLD RELEASE AGENTS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1997-02-11 | — | — | US | claimed |
| WO-1996021424-A2 | MILD COLD PEARLIZING CONCENTRATES | RHONE-POULENC INC. (US) | 1996-07-18 | — | — | WO | claimed |
| WO-1996021711-A2 | COLD PEARLIZING CONCENTRATES | RHONE-POULENC INC. (US) | 1996-07-18 | — | — | WO | claimed |
| EP-0046336-A2 | Composition and method for the control of insects | ZOECON CORPORATION (US) | 1982-02-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240197597-A1 | HAIR STYLING COMPOSITIONS | PIK3C3, POLR1C, ALKBH3 | DGKA 948/4885L3MBTL1 4399/4885FAAH 67/4885 |
| US-12070516-B2 | Hair styling compositions | PIK3C3, POLR1C, ALKBH3 | DGKA 948/4885L3MBTL1 4399/4885FAAH 67/4885 |
| US-20260115155-A1 | STABLE FORMS OF CAPSAICIN PALMITATE FOR THE TREATMENT OF PAIN | TRPV1, SPTLC3, FFAR3 | DGKA 3013/4885L3MBTL1 2262/4885FAAH 27/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.